Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rev Sci Instrum ; 92(2): 023205, 2021 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-33648096

RESUMO

Many samples of current interest in molecular physics and physical chemistry exist in the liquid phase and are vaporized for use in gas cells, diffuse gas targets, or molecular gas jets. For some of these techniques, the large sample consumption is a limiting factor. When rare, expensive molecules such as custom-made chiral molecules or species with isotopic labels are used, wasting them in the exhaust line of the pumps is quite an expensive and inefficient approach. Therefore, we developed a closed-loop recycling system for molecules with vapor pressures below atmospheric pressure. Once filled, only a few valves have to be adjusted, and a cold trap must be moved after each phase of recycling. The recycling efficiency per turn exceeds 95%.

2.
Pharmacopsychiatry ; 36(6): 317-8, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14663658

RESUMO

We report on a 17-year-old boy who developed a marked increase in serum creatine kinase (CK) (9743 U/l) during treatment with risperidone for catatonic psychosis. Known causes of elevated CK such as delirium, malignant neuroleptic syndrome, infection, cocaine overdose, trauma, and intramuscular injections were ruled out. Vital signs remained always within the normal range. On discontinuation of risperidone, serum CK concentrations returned to 105 U/l within 1 week and remained within normal limits. While a transient moderate increase in CK activity at admission may be related to acute psychosis, risperidone seems to be the causative agent for the later marked elevation. To our knowledge, this is the first reported case of risperidone-associated elevation of serum CK in an adolescent. While discontinuation of risperidone does not seem necessary in patients with a moderate increase of serum CK, withdrawal of neuroleptics is warranted in more severe cases.


Assuntos
Antipsicóticos/efeitos adversos , Creatina Quinase/sangue , Creatina Quinase/efeitos dos fármacos , Transtornos Psicóticos/tratamento farmacológico , Risperidona/efeitos adversos , Adolescente , Antipsicóticos/administração & dosagem , Catatonia/tratamento farmacológico , Humanos , Masculino , Transtornos Psicóticos/enzimologia , Risperidona/administração & dosagem
3.
Exp Neurol ; 171(1): 98-108, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11520124

RESUMO

Neural progenitor cells potentially provide a limitless, on-demand source of cells for grafting into patients with Parkinson's disease (PD) if the signals needed to control their conversion into dopamine (DA) neurons could be identified. We have recently shown that cytokines which instruct cell division and differentiation within the hematopoeitic system may provide similar functions in the central nervous system. We have shown that mitotic progenitor cells can be isolated from embryonic rat mesencephalon and that these cells respond to a combination of interleukin-1, interleukin-11, leukemia inhibitory factor, and glial cell line-derived neurotrophic factor yielding a tyrosine hydroxylase-immunoreactive (THir) phenotype in 20-25% of total cells. In the present study, 24 clonal cell lines derived from single cells of mesencephalic proliferation spheres were examined for their response to the cytokine mixture. The clone yielding the highest percentage of THir neurons (98%) was selected for further study. This clone expressed several phenotypic characteristics of DA neurons and expression of Nurr1. The response to cytokines was stable for several passages and after cryopreservation for several months. When grafted into the striatum of DA-depleted rats, these cells attenuated rotational asymmetry to the same extent as freshly harvested embryonic DA neurons. These data demonstrate that mesencephalic progenitor cells can be clonally expanded in culture and differentiated in the presence of hematopoietic cytokines to yield enriched populations of DA neurons. When transplanted, these cells provide significant functional benefit in the rat model of PD.


Assuntos
Citocinas/farmacologia , Proteínas de Ligação a DNA , Interleucina-6 , Mesencéfalo/citologia , Fatores de Crescimento Neural , Neurônios/transplante , Transtornos Parkinsonianos/terapia , Células-Tronco/citologia , Animais , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Células Clonais/citologia , Células Clonais/efeitos dos fármacos , Corpo Estriado/citologia , Corpo Estriado/metabolismo , Corpo Estriado/patologia , Criopreservação , Modelos Animais de Doenças , Dopamina/metabolismo , Fator Neurotrófico Derivado de Linhagem de Célula Glial , Sobrevivência de Enxerto/efeitos dos fármacos , Inibidores do Crescimento/farmacologia , Interleucina-1/farmacologia , Interleucina-11/farmacologia , Fator Inibidor de Leucemia , Linfocinas/farmacologia , Masculino , Mesencéfalo/embriologia , Atividade Motora/efeitos dos fármacos , Proteínas do Tecido Nervoso/farmacologia , Neurônios/citologia , Neurônios/metabolismo , Membro 2 do Grupo A da Subfamília 4 de Receptores Nucleares , Oxidopamina , Transtornos Parkinsonianos/induzido quimicamente , Transtornos Parkinsonianos/patologia , Fenótipo , Ratos , Ratos Sprague-Dawley , Células-Tronco/efeitos dos fármacos , Fatores de Transcrição/biossíntese , Tirosina 3-Mono-Oxigenase/metabolismo
4.
J Comp Neurol ; 426(1): 143-53, 2000 Oct 09.
Artigo em Inglês | MEDLINE | ID: mdl-10980489

RESUMO

Survival of embryonic dopamine (DA) neurons is extremely low (5-20%) following transplantation. Strategies to increase this survival are critical to the future of transplantation for Parkinson's disease. We demonstrate here that a factor(s) released from striatal oligodendrocyte-type 2 astrocytes (SO2A) greatly improves the survival and phenotype expression of mesencephalic DA neurons in culture while simultaneously decreasing the presence of apoptotic nuclear profiles, as detected by the TUNEL method and bisbenzamide/tyrosine hydroxylase double labeling. This SO2A-derived trophic factor(s) has minimal effects on glia and no effect on nondopaminergic mesencephalic neurons. The developmental period during which this SO2A trophic effect occurs (E14-18) coincides with the period when mesencephalic grafts are undergoing the highest rates of apoptosis, i.e., immediately following implantation. Therefore, SO2A-derived trophic factor(s) offers great potential for the augmentation of grafted DA neuron survival.


Assuntos
Apoptose/efeitos dos fármacos , Astrócitos/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Dopamina/metabolismo , Fatores de Crescimento Neural/metabolismo , Neurônios/efeitos dos fármacos , Oligodendroglia/metabolismo , Animais , Apoptose/fisiologia , Astrócitos/citologia , Transplante de Tecido Encefálico/métodos , Sobrevivência Celular/fisiologia , Células Cultivadas , Meios de Cultivo Condicionados/farmacologia , Relação Dose-Resposta a Droga , Feminino , Feto , Fator 2 de Crescimento de Fibroblastos/farmacologia , Necrose , Neurônios/metabolismo , Neurônios/transplante , Oligodendroglia/citologia , Doença de Parkinson/terapia , Fenótipo , Fator de Crescimento Derivado de Plaquetas/farmacologia , Gravidez , Ratos , Ratos Endogâmicos F344 , Células-Tronco/citologia , Células-Tronco/efeitos dos fármacos , Células-Tronco/metabolismo , Tirosina 3-Mono-Oxigenase/efeitos dos fármacos , Tirosina 3-Mono-Oxigenase/metabolismo
5.
Brain Res ; 633(1-2): 21-6, 1994 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-8137158

RESUMO

In rats treated systemically with either amphetamine, amfonelic acid or apomorphine, large numbers of cells displaying Fos-like immunoreactivity (FLI) could be seen in the lateral zone of the lateral habenula. The induction of FLI by amphetamine could be blocked either by pretreatment with haloperidol or by 6-hydroxydopamine lesions of ascending dopamine fibers at the level of the lateral hypothalamus. In contrast, a variety of stressors selectively induced FLI in the most medial portion of the lateral habenula. These findings support the concept of a functional differentiation of the medial and lateral regions of the lateral habenula and provide further evidence for involvement of the habenula in the circuitry of the basal ganglia.


Assuntos
Dopamina/fisiologia , Proteínas Oncogênicas v-fos/metabolismo , Estresse Psicológico/metabolismo , Tálamo/metabolismo , Animais , Apomorfina/farmacologia , Dextroanfetamina/farmacologia , Meio Ambiente , Haloperidol/farmacologia , Imuno-Histoquímica , Cloreto de Lítio/farmacologia , Masculino , Ácido Nalidíxico/análogos & derivados , Naftiridinas/farmacologia , Neostriado/efeitos dos fármacos , Neostriado/metabolismo , Proteínas Oncogênicas v-fos/imunologia , Oxidopamina/farmacologia , Prosencéfalo/efeitos dos fármacos , Prosencéfalo/metabolismo , Ratos , Ratos Sprague-Dawley , Restrição Física , Substância Negra/efeitos dos fármacos , Substância Negra/metabolismo , Tálamo/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA